Antidepressants and type 2 diabetes: highways to knowns and unknowns

Type 2 diabetes (T2D) is a metabolic disease caused by the development of insulin resistance (IR), relative insulin deficiency, and hyperglycemia. Hyperglycemia-induced neurochemical dysregulation activates the progression of depression in T2D patients. Therefore, management of depression by antidep...

Descripción completa

Detalles Bibliográficos
Autores principales: Alruwaili, Nahi Sabih, Al-Kuraishy, Hayder M., Al-Gareeb, Ali I., Albuhadily, Ali K., Ragab, Amany E., Alenazi, Ahmad Awad, Alexiou, Athanasios, Papadakis, Marios, Batiha, Gaber El-Saber
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470155/
https://www.ncbi.nlm.nih.gov/pubmed/37653558
http://dx.doi.org/10.1186/s13098-023-01149-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470155/
https://www.ncbi.nlm.nih.gov/pubmed/37653558
http://dx.doi.org/10.1186/s13098-023-01149-z

Ejemplares similares